National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

iodine I 125 anti-EGFR-425 monoclonal antibody
A radioimmunoconjugate consisting of a murine IgG2a monoclonal antibody directed against the human epidermal growth factor receptor (EGFR) labeled with iodine I 125 with potential antineoplastic activity. Iodine I 125 anti-EGFR-425 monoclonal antibody binds specifically to the epidermal growth factor receptor (EGFR). Upon binding to EGFR-expressing tumor cells, this agent is internalized, selectively delivering a potentially cytotoxic dose of gamma radiation. EGFR is a receptor tyrosine kinase that may be overexpressed on the cell surfaces of various solid tumors. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:iodine 125-labeled anti-EGFR-425 monoclonal antibody
iodine 125-labeled anti-epidermal growth factor receptor-425 monoclonal antibody



Previous:iodine I 124, iodine I 124 chimeric monoclonal antibody G250, iodine I 124 iodo-azomycin galactopyranoside, iodine I 124 iododeoxyuridine, iodine I 125
Next:iodine I 131, iodine I 131 chimeric monoclonal antibody G-250, iodine I 131 ethiodized oil, Iodine I 131 Lipiodol, iodine I 131 monoclonal antibody 3F8

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov